Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schraiber is a Brazilian pharmaceutical company specializing in the development and manufacture of homeopathic medicines, herbal products, and natural supplements. Founded in 1988, the company focuses on providing alternative and complementary health solutions, including a wide range of phytotherapeutic treatments and vegan-friendly cosmetics. Schraiber is recognized for its commitment to natural ingredients and cruelty-free practices, serving the Brazilian market through pharmacies and specialized health stores. Their product portfolio encompasses various therapeutic areas such as stress management, digestive health, and nutritional support. The company is a pioneer in the Brazilian market for vegan-certified health products and maintains high quality standards in accordance with ANVISA regulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schraiber.